Complete Story
 

Now Approved PEPAXTO (melphalan flufenamide) from Oncopeptides, Inc.

Oncopeptides, Inc. is pleased to announce the FDA has granted approval for PEPAXTO® (melphalan flufenamide).  For more information, please see the full Prescribing Information and press release U.S. Press Release

 

Printer-Friendly Version